Synonym: 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2,2,1]heptan-1(S)-yl)methylsulfonyl)-4-(2-methylphenyl)piperazine hydrochloride
CAS Number: 160312-62-9
Empirical Formula (Hill Notation): C26H42O5N4S2 · HCl
Molecular Weight: 591.23
MDL Number: MFCD09753328
Linear Formula: C26H42O5N4S2 · HCl
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
white |
| form |
powder |
| InChI |
1S/C26H42N4O5S2.ClH/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33;/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31);1H/t20-,21+,23+,26-;/m1./s1 |
| InChI key |
GIUFQWFJHXXXEQ-SWJTYIIKSA-N |
| originator |
Merck & Co., Inc., Kenilworth, NJ, U.S. |
| Quality Level |
100  |
| SMILES string |
Cl.Cc1ccccc1N2CCN(CC2)S(=O)(=O)C[C@]34CC[C@H](C[C@@H]3NC(=O)[C@@H](N)CCS(C)(=O)=O)C4(C)C |
| solubility |
H2O: soluble 20 mg/mL |
| storage temp. |
−20°C |
| Biochem/physiol Actions: |
L-368,899 is a non-peptide oxytocin receptor (OTR) antagonist. |
| Features and Benefits: |
This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S. . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
5 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
51111800 |
